Eastman Chemical Co. 10-Q Summary (Q2 2008)
Business Context and Reporting Period
This is an unaudited quarterly report (Form 10-Q) for Eastman Chemical Company for the period ended June 30, 2008. The company operates in five segments: Coatings, Adhesives, Specialty Polymers, and Inks (CASPI); Fibers; Performance Chemicals and Intermediates (PCI); Performance Polymers; and Specialty Plastics (SP). The reporting period reflects the completion of the divestiture of European PET operations (Netherlands and UK) in Q1 2008, which are now classified as discontinued operations.
Key Financial Metrics
| Metric (in millions) | Q2 2008 | Q2 2007 | YTD 2008 | YTD 2007 |
|---|---|---|---|---|
| Sales | $1,834 | $1,764 | $3,561 | $3,401 |
| Gross Profit | $321 | $309 | $658 | $595 |
| Operating Earnings | $172 | $160 | $340 | $314 |
| Net Earnings | $115 | $105 | $248 | $182 |
| Diluted EPS | $1.48 | $1.22 | $3.16 | $2.13 |
| Cash from Operations (YTD) | $79 | $99 | $79 | $99 |
| Cash & Equivalents (End of Period) | $562 | $891 | $562 | $891 |
| Total Debt (Long-term + Current) | $1,440 | $1,607 | $1,440 | $1,607 |
Margins: Gross margin was 18% for Q2 2008 and 18% for Q2 2007. Operating margin was 9.4% for Q2 2008 compared to 9.1% for Q2 2007.
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 4% in Q2 and 5% YTD compared to 2007. Excluding contract sales and divested Latin American PET facilities, organic sales grew 8% in Q2 and 9% YTD, driven primarily by price increases offsetting lower volumes.
- Profitability: Operating earnings rose 8% in both Q2 and YTD periods. This growth occurred despite significant raw material and energy cost increases (approx. $200M in Q2 and $350M YTD) and was aided by a lower effective tax rate (25% vs 33% in 2007) due to a federal gasification investment tax credit.
- Discontinued Operations: The company recognized an $18 million gain (net of tax) in the first six months of 2008 from the sale of PET facilities in the Netherlands and UK. There were no discontinued operations results in Q2 2008.
- Restructuring: Asset impairments and restructuring charges were $3 million in Q2 2008 and $20 million YTD 2008, primarily related to severance and site closure costs in the UK and South Carolina.
Guidance, Outlook, and Risks
- 2008 Outlook: Management expects capital spending to exceed $600 million. They anticipate maintaining strong volumes despite economic uncertainty and expect the effective tax rate to be approximately 30% including the gasification tax credit.
- Segment Specifics:
- PCI: Expected to have operating margins at the high end of the 5-10% range.
- CASPI: Expected to maintain solid earnings slightly below the typical 15-20% operating margin range.
- Performance Polymers: Profitability expected to improve following the completion of the South Carolina facility transformation and cost reductions.
- Q3 2008 Outlook: Management expects EPS from continuing operations to be similar to Q3 2007, excluding gains and charges related to strategic actions. They anticipate a softening U.S. economy and continued significant rises in raw material costs.
- Risks: Key risks include volatility in raw material and energy costs, global economic conditions, foreign currency exchange rates, and the ability to pass cost increases to customers. The company is also subject to environmental liabilities and asbestos litigation, though management does not believe these will have a material adverse effect.
Investor Verification Checklist
- Raw Material Hedging: Verify the extent of hedging programs in place to mitigate the impact of rising propane, paraxylene, and natural gas costs.
- Gasification Project Financing: Confirm the status of non-recourse financing for the Beaumont, Texas industrial gasification project, expected to break ground in early 2009.
- Working Capital Trends: Monitor inventory levels, which increased significantly due to higher raw material costs, impacting operating cash flow.
- Share Repurchases: Track the remaining $348 million available under the $700 million share repurchase authorization.
- Discontinued Operations: Ensure the $18 million gain from the European PET sale is correctly excluded from continuing operations analysis.